CD274 and non-small cell lung carcinoma: Recently, our group showed that the presence of CTCs, particularly of programmed cell death ligand 1-positive (PD-L1+) CTCs, in patients with NSCLC is a robust prognostic marker that is independent of treatment and molecular subtyping [8].